SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $7,000 | -12.5% | 905 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $8,000 | -33.3% | 905 | -6.2% | 0.00% | -50.0% |
| Q2 2021 | $12,000 | 0.0% | 965 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $12,000 | -20.0% | 965 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $15,000 | +66.7% | 965 | +6.6% | 0.00% | +50.0% |
| Q3 2020 | $9,000 | +12.5% | 905 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $8,000 | – | 905 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lombard Odier Asset Management (Switzerland) SA | 1,539,994 | $11,550,000 | 0.74% |
| Golden State Equity Partners | 143,768 | $1,078,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 765,000 | $5,975,000 | 0.40% |
| WASATCH ADVISORS LP | 10,960,982 | $82,207,000 | 0.34% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $332,000 | 0.32% |
| EMC Capital Management | 61,394 | $460,000 | 0.25% |
| Rokos Capital Management LLP | 539,860 | $4,108,000 | 0.25% |
| Long Focus Capital Management, LLC | 245,000 | $1,838,000 | 0.24% |
| Vanguard Capital Wealth Advisors | 33,380 | $250,000 | 0.18% |
| Fort Sheridan Advisors LLC | 74,898 | $562,000 | 0.16% |